Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

$6.3 billion and $6.5 billion.
  • Total Actavis Specialty Brands segment revenue of between $550 million and $600 million.
  • Total Anda Distribution segment revenue of between $1.0 billion and $1.2 billion.
  • Adjusted non-GAAP earnings for 2013 is expected to be between $7.70 and $8.10 per diluted share.*
  • Adjusted EBITDA for 2013 is expected to be between $1.87 billion and $1.94 billion.*

    • *See Tables 6 and 7 and accompanying notes. 

    Webcast and Conference Call DetailsActavis will host a conference call and webcast today at 8:30 a.m. Eastern Standard Time to discuss fourth quarter and full year 2012 results, the outlook for 2013 and recent corporate developments.  The dial-in number to access the call is US/Canada (877) 251-7980, International (706) 643-1573.  The Conference ID is 94810189.

    A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Time on March 5, 2013.  The replay may be accessed by dialing (855) 859-2056 and entering pass code 94810189.  From international locations, the replay may be accessed by dialing (404) 537-3406 and entering the same pass code.  To access the webcast, go to Actavis' Investor Relations Web site at http://ir.actavis.com.  A replay of the webcast will also be available.

    About Actavis, Inc.
    Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. 

    Actavis is the world's third-largest generics prescription drug manufacturer.&
    '/>"/>

    SOURCE Actavis, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Watson to Acquire Actavis Group for EUR4.25 Billion
    2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
    3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
    4. Watson and Actavis Receive FTC Second Request
    5. Watson Announces New Name -- Actavis -- for Global Operations
    6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
    7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
    8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
    9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    11. Aethlon Medical Note: Fiscal Year Revenue Guidance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/20/2013)... , May 20, 2013 With herbal medicines ... available from the U.S. Pharmacopeial Convention (USP) will provide ... of the herbal ingredients used in these products. Today, ... in the new Herbal Medicines Compendium ( ... at hmc.usp.org . HMC ...
    (Date:5/19/2013)... -- Claret Medical, Inc. announced the publication of an original ... et al., Histopathology of Embolic Debris Captured During Transcatheter ... May 7 th this research is the result of ... Netherlands and the pathology team of Dr. ... Gaithersburg, Maryland.  This is the first time ...
    (Date:5/19/2013)... , May 20, 2013  Whole-cell pertussis vaccines were ... vaccines during a large recent outbreak, according to a ... Whole-cell pertussis vaccines, also called DTwP, were available from ... concerns that ultimately led to the development of acellular ... late 1990s, the United States ...
    Breaking Medicine Technology:New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4
    ... analysis of the effects of omega-3 essential fatty acids ... of millions of people with depression. Two critical omega-3 ... supplements but not manufactured by the body—Eicosapentenoic acid (EPA) ... brain functioning and have antidepressant benefits that have not ...
    ... Texas, Dec. 7, 2010 Luminex Corporation (Nasdaq: ... producer of transplant diagnostic products, have agreed to a ... developing platforms and technologies for human leukocyte antigen (HLA) ... Begun in 2000, their dedicated collaboration has resulted in ...
    Cached Medicine Technology:Omega-3 Supplements Show Promise in Alleviating Depression 2Luminex and One Lambda Renew Long-Term Strategic Partnership 2Luminex and One Lambda Renew Long-Term Strategic Partnership 3
    (Date:5/20/2013)... Reporter , , SATURDAY, May 18 (HealthDay News) -- A ... colonoscopies may help them miss fewer suspicious growths during ... the recommended screening tests for colorectal cancer, which is ... in the United States. To perform a colonoscopy, ... mounted on the end called a colonoscope to view ...
    (Date:5/20/2013)... Reporter , , SUNDAY, May 19 (HealthDay News) -- Sleep ... by endlessly and subconsciously waking them up, becomes more ... raises the possibility that it may somehow cause -- ... Don,t worry just yet if you have sleep apnea. ... may be no connection between the two conditions. Still, ...
    (Date:5/20/2013)... If you,ve got bunions, chances are others in your ... new study finding the condition is often passed down ... issue of Arthritis Care & Research , researchers ... such as bunions or other toe deformities. "Our ... common foot disorders in older adults," Dr. Marian Hannan, ...
    (Date:5/20/2013)... FL (May 20, 2013) Research presented at Digestive ... bowel syndrome with diarrhea (IBS-D) and hepatitis C. ... suffering from IBS-D. In the phase II study, researchers ... more than 50 percent of the individuals treated. ... medicines for IBS with constipation, we haven,t seen the ...
    (Date:5/20/2013)... Minn. Patients with inflammatory bowel disease (IBD) are ... cancer, report researchers at Mayo Clinic. Researchers found that ... for the disease. The findings were presented at the ... More than 1.5 million Americans have Crohn,s disease or ... bowel disease. Both conditions inflame the lining of the ...
    Breaking Medicine News(10 mins):Health News:New Device May Show Doctors More of the Colon 2Health News:New Device May Show Doctors More of the Colon 3Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 2Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 3Health News:Many Can Blame Family for Their Bunions 2Health News:Pharmaceutical advances offer new options for health outcomes 2
    ... 27, 2011The nature of cell phone communication between a ... their relationship, and much depends on who initiates the ... according to an illuminating study reported online in ... published by Mary Ann Liebert, Inc. ( www.liebertpub.com ). ...
    ... acting out their independence through heavy, episodic drinking. But ... kind nationally, is showing how binge drinking among adolescents and ... that,s still under development at this age. Researcher Tim ... is presenting the findings this week at the 34th annual ...
    ... By Amanda Gardner HealthDay Reporter , MONDAY, June ... is calling for a ban on all junk food and ... of slowing the rising tide of obesity among young people. ... of Pediatrics , the American Academy of Pediatrics (AAP) ...
    ... breast cancer in the U.S. did not receive postmastectomy ... outlining PMRT as a potentially lifesaving treatment, according to ... Cancer Center. The study, published in the July ... rates for women with advanced breast cancer have remained ...
    ... available in German . The German Federal ... in research and development funding for the efficient production of ... FRM II. In a 2009 feasibility study, the Technische Universitaet ... neutron source in Garching can produce about half of the ...
    ... of Scott & White Healthcare, is the only physician in ... to Becker,s Hospital Review annual list of Physician Leaders of ... medicine and management, these men and women represent some of ... According to Becker,s, physician leaders make up an exceptional ...
    Cached Medicine News:Health News:Study reveals possible brain damage in young adult binge-drinkers 2Health News:Doctors Urge Ban on Junk Food Ads During Kids' Shows 2Health News:Doctors Urge Ban on Junk Food Ads During Kids' Shows 3Health News:Nearly half of women with advanced breast cancer in the US not receiving life-saving treatment 2Health News:Nearly half of women with advanced breast cancer in the US not receiving life-saving treatment 3Health News:Cancer diagnosis isotopes from Garching 2
    ... enables hospitals to standardize ... to a single temperature ... monitoring disposale probes and ... in their manufacture and ...
    ... The pause of a heartbeat. The ... of rhythmic breathing. These vital signs are ... check. DeRoyals line of Temperature Monitoring products ... the information needed to provide the most ...
    ... The pause of a heartbeat. The ... of rhythmic breathing. These vital signs are ... check. DeRoyals line of Temperature Monitoring products ... the information needed to provide the most ...
    ... stabilization of the capsular bag in complicated ... Tension Ring has application in several different ... available for patients with pseudoexfoliation syndrome. Many ... tension ring, especially those in whom you ...
    Medicine Products: